| 0 (0%) | 09-27 11:15 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 267.42 | 1-year : | 312.35 |
| Resists | First : | 228.96 | Second : | 267.42 |
| Pivot price | 224.16  |
|||
| Supports | First : | 218.33 | Second : | 211.77 |
| MAs | MA(5) : | 228.74 | MA(20) : | 221.52 |
| MA(100) : | 210.94 |
MA(250) : | 192.53 |
|
| MACD | MACD : | 4.1  |
Signal : | 3.4 |
| %K %D | K(14,3) : | 98.6 |
D(3) : | 98.6 |
| RSI | RSI(14): 82.9 | |||
| 52-week | High : | 228.96 | Low : | 123.76 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SGEN ] has closed below upper band by 30.6%. Bollinger Bands are 149.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 229.27 - 230.4 | 230.4 - 231.32 |
| Low: | 225.54 - 227.11 | 227.11 - 228.39 |
| Close: | 226.56 - 228.92 | 228.92 - 230.83 |
Tue, 17 Sep 2024
Opinion | Jonathan Haidt | SGen Z Has Regrets. - NYU Stern
Wed, 07 Jun 2023
Profit From The Pfizer Takeover Of Seagen (NASDAQ:SGEN) - Seeking Alpha
Tue, 23 May 2023
SGEN, ACAD & BMEA Drove Baker Brothers Advisors' Q1 Returns as ASND and HZNP Were Culled - 24/7 Wall St.
Tue, 14 Mar 2023
StockWatch: Antitrust Fears Dampen Support for $43B Pfizer-Seagen Deal: - Mary Ann Liebert, Inc.
Tue, 14 Mar 2023
Seagen (SGEN) Set to be Acquired by Pfizer for $43 B, Stock Up - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 189 (M) |
| Shares Float | 130 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 88.8 (%) |
| Shares Short | 9,580 (K) |
| Shares Short P.Month | 10,420 (K) |
| EPS | -4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.52 |
| Profit Margin | -32.7 % |
| Operating Margin | -35.3 % |
| Return on Assets (ttm) | -13 % |
| Return on Equity (ttm) | -28 % |
| Qtrly Rev. Growth | 27.1 % |
| Gross Profit (p.s.) | 1.1 |
| Sales Per Share | 12.19 |
| EBITDA (p.s.) | -3.6 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -540 (M) |
| Levered Free Cash Flow | -277 (M) |
| PE Ratio | -57.19 |
| PEG Ratio | 0.5 |
| Price to Book value | 16.91 |
| Price to Sales | 18.76 |
| Price to Cash Flow | -79.9 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|